Clinicopathologic analysis of upper urinary tract carcinoma with variant histology

Archiv für pathologische Anatomie und Physiologie und für klinische Medicin - Tập 477 - Trang 111-120 - 2020
Inês Rolim1,2, Vanessa Henriques2, Nídia Rolim3, Ana Blanca4, Rita Canas Marques2, Metka Volavšek5, Inês Carvalho2, Rodolfo Montironi6, Alessia Cimadamore6, Maria R. Raspollini7, Liang Cheng8, Antonio Lopez-Beltran9,10
1Serviço de Anatomia Patológica, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E, Lisbon, Portugal
2Anatomic Pathology Service, Champalimaud Clinical Center, Lisbon, Portugal
3Serviço de Urologia, Hospital de Egas Moniz, Lisbon, Portugal
4Maimonides Biomedical Research Institute of Cordoba, Cordoba, Spain
5Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
6Institute of Pathological Anatomy and Histopathology, Ancona, Italy
7Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy
8Departments of Pathology and Laboratory Medicine and Urology, Indiana University, Indianapolis, USA
9Department of Surgery and Pathology, Faculty of Medicine, Cordoba University, Cordoba, Spain
10Champalimaud Clinical Center, Lisbon, Portugal

Tóm tắt

We report on the clinicopathologic features of 115 cases of high-grade urothelial carcinoma of the upper urinary tract with variant histology present in 39 (34%). Variant histology was typically seen in high pathological stage (pT2-pT4) (82%, 32 cases) patients with lower survival rate (70%, 27 cases, median survival 31 months) and consisted in urothelial with one (23%), two (3%), and three or more variants (3%); 4% of cases presented with pure variant histology. Squamous divergent differentiation was the most common variant (7%) followed by sarcomatoid (6%) and glandular (4%), followed by 3% each of micropapillary, diffuse-plasmacytoid, inverted growth, clear cell glycogenic, or lipid-rich. The pseudo-angiosarcomatous variant is seen in 2%, and 1% each of nested, giant-cell, lymphoepithelioma-like, small-cell, trophoblastic, rhabdoid, microcystic, lymphoid-rich stroma, or myxoid stroma/chordoid completed the study series. Loss of mismatch repair protein expression was identified in one case of upper urinary tract carcinoma with inverted growth variant (3.6%). Variant histology was associated to pathological stage (p = 0.007) and survival status (p = 0.039). The univariate survival analysis identified variant histology as a feature of lower recurrence-free survival (p = 0.046). Our findings suggest that variant histology is a feature of aggressiveness in urothelial carcinoma of the upper urinary tract worth it to be reported.

Từ khóa


Tài liệu tham khảo

Siegel R, Miller KD, Jemal A (2018) Cáncer statistics. CA Cancer J Clin 68:7–30. https://doi.org/10.3322/caac.21442

Bianconi M, Cimadamore A, Faloppi L, Scartozzi M, Santoni M, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R (2019) Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter. Ther Adv Urol 8:1756287218815372. https://doi.org/10.1177/1756287218815372

Mbeutcha A, Rouprêt M, Kamat AM, Karakiewicz PI, Lawrentschuk N, Novara G, Raman JD, Seitz C, Xylinas E, Shariat SF (2017) Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review. World J Urol 35:337–353. https://doi.org/10.1007/s00345-016-1826-2

Lopez-Beltran A, Cheng L, Raspollini MR et al (2017) Variants of bladder cancer: the pathologist’s point of view. Eur Urol Suppl 16:210–222. https://doi.org/10.1016/j.eursup.2017.09.004

Moch H, Humphrey PA, Ulbright TM, Reuter VE (2016) WHO classification of tumours of the urinary system and male genital organs, 4th edn. IARC, Lyon

Amin MB (2009) Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod Pathol. https://doi.org/10.1038/modpathol.2009.26

Kim SP, Frank I, Cheville JC, Thompson RH, Weight CJ, Thapa P, Boorjian SA (2012) The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. J Urol 188:405–409. https://doi.org/10.1016/j.juro.2012.04.020

Phelan A, Lopez-Beltran A, Montironi R, Zhang S, Raspollini MR, Cheng M, Kaimakliotis HZ, Koch MO, Cheng L (2018) Inherited forms of bladder cancer: a review of lynch syndrome and other inherited conditions. Future Oncol 14:277–290. https://doi.org/10.2217/fon-2017-0346

Rink M, Robinson BD, Green DA, Cha EK, Hansen J, Comploj E, Margulis V, Raman JD, Ng CK, Remzi M, Bensalah K, Kabbani W, Haitel A, Rioux-Leclercq N, Guo CC, Chun FK, Kikuchi E, Kassouf W, Sircar K, Sun M, Sonpavde G, Lotan Y, Pycha A, Karakiewicz PI, Scherr DS, Shariat SF (2012) Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol 188:398–404. https://doi.org/10.1016/j.juro.2012.04.009

Lopez-Beltran A, Cheng L (2006) Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum Pathol 37:1371–1388. https://doi.org/10.1016/j.humpath.2006.05.009

Chalasani V, Chin JL, Izawa JI (2009) Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. J Can Urol Assoc 3:193–198

Hayashi H, Mann S, Kao CS, Grignon D, Idrees MT (2017) Variant morphology in upper urinary tract urothelial carcinoma: a 14-year case series of biopsy and resection specimens. Hum Pathol 65:209–216. https://doi.org/10.1016/j.humpath.2017.05.001

Sakano S, Matsuyama H, Kamiryo Y, Hayashida S, Yamamoto N, Kaneda Y, Nasu T, Baba Y, Shimabukuro T, Suga A, Yamamoto M, Aoki A, Takai K, Yoshihiro S, Oba K, Yamaguchi Uro-Oncology Group (2015) Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma. Int J Clin Oncol 20:362–368. https://doi.org/10.1007/s10147-014-0721-3

Perez-Montiel D, Wakely PE, Hes O, Michal M, Suster S (2006) High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants. Mod Pathol 19:494–503. https://doi.org/10.1038/modpathol.3800559

Olgac S, Mazumdar M, Dalbagni G, Reuter VE (2004) Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol 28:1545–1552

Tang Q, Xiong G, Li X, Fang D, Xi C, Zhang L, Yang K, Yao L, Zhang C, Yu W, He Q, Gong K, He Z, Zhou L (2016) The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy. World J Urol 34:871–877. https://doi.org/10.1007/s00345-015-1715-0

Shibing Y, Turun S, Qiang W et al (2015) Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy. Urol Oncol 33:204e9–204e16. https://doi.org/10.1016/j.urolonc.2015.02.010

Kim JK, Moon KC, Jeong CW, Kwak C, Kim HH, Ku JJ (2017) Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Urol Oncol 35:458.e9–458.e15

Masson-Lecomte A, Colin P, Bozzini G et al (2014) Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol 32:531–537

Lopez-Beltran A, Paner G, Blanca A, Montironi R, Tsuzuki T, Nagashima Y, Chuang SS, Win KT, Madruga L, Raspollini MR, Cheng L (2017) Lymphoepithelioma-like carcinoma of the upper urinary tract. Virchows Arch 470:703–709. https://doi.org/10.1007/s00428-017-2117-z

Lopez-Beltran A, Henriques V, Montironi R, Cimadamore A, Raspollini MR, Cheng L (2019) Variants and new entities of bladder cancer. Histopathology 74:77–96. https://doi.org/10.1111/his.13752

Cimadamore A, Scarpelli M, Santoni M, Cheng L, Lopez-Beltran A, Montironi R (2018) Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy. Exp Rev Mol Diagn 18:1021–1028. https://doi.org/10.1080/14737159.2018.1549490

Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W, Spiess PE, Lotan Y, Ye D, Fernández MI, Kikuchi E, Chade DC, Babjuk M, Grollman AP, Thalmann GN (2017) Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol 35:379–387. https://doi.org/10.1007/s00345-016-1928-x

Elawdy M, Taha DE, Elbaset MA, Abouelkheir RT, Osman Y (2016) Histopathologic characteristics of upper tract urothelial carcinoma with emphasis on their impact in cancer survival: a single institute experience in 305 patients with long-term follow-up. Clin Genitourin Cancer. https://doi.org/10.1016/j.clgc.2016.04.017

Langner C, Hutterer G, Chromecki T, Rehak P, Zigeuner R (2006) Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Arch 448:604–611

Harper HL, McKenney JK, Heald B et al (2017) Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome. Mod Pathol 30:146–156

Thông tin
Thông tin xuất bản

Archiv für pathologische Anatomie und Physiologie und für klinische Medicin

Tập 477

111-120

Thông tin tác giả